Determinants of corticotropin releasing factor. Receptor selectivity of corticotropin releasing factor related peptides

Journal of Medicinal Chemistry

Volumn 47, Issue 13, 2004, Pages 3450-3454

  Mazur, Adam W ^a,b   Wang, Feng ^a   Tcheiner, Michelle ^a   Donnelly, Elizabeth ^a   Isfort, Robert J ^a,b  

^a PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

^b Girindus America Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR DERIVATIVE; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; PEPTIDE HORMONE; SAUVAGINE; UNCLASSIFIED DRUG; UROCORTIN 2; UROCORTIN III; UROCORTIN RELATED PEPTIDE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; DRUG RECEPTOR BINDING; DRUG RESEARCH; PROTEIN FAMILY; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR SENSITIVITY;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; CORTICOTROPIN-RELEASING HORMONE; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE;

EID: 2942571194     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm049883l     Document Type: Article

References (20)

1. Gilligan, P. J.; Robertson, D. W.; Zaczek, R. Corticotropin releasing factor (CRF) receptor modulators: progress and opportunities for new therapeutic agents. J. Med. Chem. 2000, 43, 1641-1660.
2. Contarino, A. a. G. L. Targeted mutations of the corticotropin-releasing factory system effects on physiology and behavior. Neuropeptides 2002, 36, 103-116.
3. De Souza, E. B. Corticotrpin-releasing factor receptors: physiology; pharmacology; biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology 1995, 20, 789-819.
4. Hashimoto, K.; Makino, S.; Asaba, K.; Nishiyama, M. Physiological roles of the corticotropin-releasing hormone receptor type 2. Endocr. J. 2001, 48, 1-9.
5. Owens, M. J.; Nemeroff, C. B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 1991, 43, 425-473.
6. Beyermann, M.; Rothemund, S.; Heinrich, N.; Fechner, K.; Furkert, J.; Dathe, M.; Winter, R.; Krause, E.; Bienert, M. A role for a helical connector between two receptor binding sites of a long-chain peptide hormone. J. Biol. Chem. 2000, 275, 5702-5709.
7. Nielsen, S. M.; Nielsen, L. Z.; Hjorth, S. A.; Perrin, M. H.; Vale, W. W. Constitutive activation of tethered-peptide/corticotropin-releasing factor receptor chimeras. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 10277-10281.
8. Vale, W.; Spiess, J.; Rivier, C.; Rivier, J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981, 213, 1394-1397.
9. Jahn, O.; Eckart, K.; Sydow, S.; Hofmann, B. A.; Spiess, J. Pharmacological characterization of recombinant rat corticotropin releasing factor binding protein using different sauvagine analogs. Peptides (N. Y.) 2001, 22, 47-56.
10. Hinkle, R. T.; Donnelly, E.; Cody, D. B.; Samuelsson, S. J.; Lange, J. S.; Bauer, M. B.; Tarnopolsky, M.; Sheldon, R. J.; Coste, S. C.; Tobar, E.; Stenzel-Poore, M. P.; Isfort, R. J. Activation of the Corticotropin Releasing Factor 2 Receptor Modulates Skeletal Muscle Mass under Physiological and Pathological Conditions. Am. J. Physiol. 2003, 285, E889-E898.
11. Reyes, T. M.; Lewis, K.; Perrin, M. H.; Kunitake, K. S.; Vaughan, J.; Arias, C. A.; Hogenesch, J. B.; Gulyas, J.; Rivier, J.; Vale, W. W.; Sawchenko, P. E. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc. Natl. Acad. Sci. U.S.A. 2002, 98, 2843-2848.
12. 1H NMR and distance geometry with restrained molecular dynamics. Protein Eng. 1993, 6, 149.
13. Keller, P. A.; Elfick, L.; Garner, J.; Morgan, J.; McCluskey, A. Corticotropin releasing hormone: therapeutic implications and medicinal chemistry developments. Bioorg. Med. Chem. 2000, 8, 1213-1223.
14. Kornreich, W. D.; Galyean, R.; Hernandez, J. F.; Craig, A. G.; Donaldson, C. J.; Yamamoto, G.; Rivier, C.; Vale, W.; Rivier, J. Alanine series of ovine corticotropin releasing factor (oCRF): a structure-activity relationship study. J. Med. Chem. 1992, 35, 1870-1876.
15. Rivier, J.; Rivier, C.; Galyean, R.; Miranda, A.; Miller, C.; Craig, A. G.; Yamamoto, G.; Brown, M.; Vale, W. Single point D-substituted corticotropin-releasing factor analogs: effects on potency and physicochemical characteristics. J. Med. Chem. 1993, 36, 2851-2859.
16. Spyroulias, G. A.; Papazacharias, S.; Pairas, G.; Cordopatis, P. Monitoring the structural consequences of Phe12 → D-Phe and Leu15 → Aib substitution in human/rat corticotropin releasing hormone: Implications for design of CRH antagonists. Eur. J. Biochem. 2002, 269, 6009-6019.
17. Andrews, M. J. I.; Tabor, A. B. Forming stable helical peptides using natural and artificial amino acids. Tetrahedron 1999, 55, 11711-11743.
18. Etzkorn, F. A.; Travins, J. M.; Hart, S. A. Rare protein turns: g-turn, helix-turn-helix, and cis-proline mimics. Adv. Amino Acid Mimetics Peptidomimetics 1999, 2, 125-163.
19. Hsu, S. Y.; Hsueh, A. J. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat. Med. 2001, 7, 605-611.
20. Lewis, K.; Li, C.; Perrin, M. H.; Blount, A.; Kunitake, K.; Donaldson, C.; Vaughan, J.; Reyes, T. M.; Gulyas, J.; Fischer, W.; Bilezikjian, L.; Rivier, J.; Sawchenko, P. E.; Vale, W. W. Identification of urocortin III; an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 7570-7575.